These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26599153)

  • 1. Empirical fitness models for hepatitis C virus immunogen design.
    Hart GR; Ferguson AL
    Phys Biol; 2015 Nov; 12(6):066006. PubMed ID: 26599153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational design of hepatitis C virus immunogens from host-pathogen dynamics over empirical viral fitness landscapes.
    Hart GR; Ferguson AL
    Phys Biol; 2018 Nov; 16(1):016004. PubMed ID: 30484433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.
    Abdel-Hady KM; Gutierrez AH; Terry F; Desrosiers J; De Groot AS; Azzazy HM
    Hum Vaccin Immunother; 2014; 10(8):2366-77. PubMed ID: 25424944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity.
    Yusim K; Fischer W; Yoon H; Thurmond J; Fenimore PW; Lauer G; Korber B; Kuiken C
    J Gen Virol; 2010 May; 91(Pt 5):1194-206. PubMed ID: 20053820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitope.
    Tan AC; Eriksson EM; Kedzierska K; Deliyannis G; Valkenburg SA; Zeng W; Jackson DC
    Antiviral Res; 2012 May; 94(2):168-78. PubMed ID: 22504097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
    Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B
    Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.
    Encke J; Radunz W; Eisenbach C; Geib J; Gehrke S; Pfaff E; Stremmel W
    Eur J Clin Invest; 2007 May; 37(5):396-406. PubMed ID: 17461986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
    Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
    Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses.
    Fournillier A; Gerossier E; Evlashev A; Schmitt D; Simon B; Chatel L; Martin P; Silvestre N; Balloul JM; Barry R; Inchauspé G
    Vaccine; 2007 Oct; 25(42):7339-53. PubMed ID: 17875349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design.
    Roohvand F; Kossari N
    Expert Opin Ther Pat; 2011 Dec; 21(12):1811-30. PubMed ID: 22022980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse.
    Eisenbach C; Freyse A; Lupu CM; Weigand K; Ernst E; Hoyler B; Stremmel W; Bugert JJ; Encke J
    Vaccine; 2006 Jun; 24(24):5140-8. PubMed ID: 16713033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient induction of mouse immune responses to hepatitis C virus by viral core protein-carrying attenuated Salmonella typhimurium.
    Liao XL; Ren H; Zhao P; Zhu SY; Cao J; Chen ZH; Zhao LJ; Pan W; Feitelson MA; Qui ZT
    Viral Immunol; 2007 Sep; 20(3):469-78. PubMed ID: 17931117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C vaccine: supply and demand.
    Strickland GT; El-Kamary SS; Klenerman P; Nicosia A
    Lancet Infect Dis; 2008 Jun; 8(6):379-86. PubMed ID: 18501853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.
    Frelin L; Ahlén G; Alheim M; Weiland O; Barnfield C; Liljeström P; Sällberg M
    Gene Ther; 2004 Mar; 11(6):522-33. PubMed ID: 14999224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys.
    Park SH; Lee SR; Hyun BH; Kim BM; Sung YC
    Vaccine; 2008 Jul; 26(32):3978-83. PubMed ID: 18556097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
    Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
    Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.